These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine. Kurtis JD; Hollingdale MR; Luty AJ; Lanar DE; Krzych U; Duffy PE Trends Parasitol; 2001 May; 17(5):219-23. PubMed ID: 11323304 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum. Kurtis JD; Lanar DE; Opollo M; Duffy PE Infect Immun; 1999 Jul; 67(7):3424-9. PubMed ID: 10377122 [TBL] [Abstract][Full Text] [Related]
5. Plasmodium falciparum liver-stage antigen-1 peptide-specific interferon-gamma responses are not suppressed during uncomplicated malaria in African children. Luty AJ; Bongartz M; Rezbach P; Faucher JF; Hollingdale MR; Kremsner PG Eur Cytokine Netw; 2001; 12(4):647-53. PubMed ID: 11781192 [TBL] [Abstract][Full Text] [Related]
6. The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria. Karch CP; Doll TAPF; Paulillo SM; Nebie I; Lanar DE; Corradin G; Burkhard P J Nanobiotechnology; 2017 Sep; 15(1):62. PubMed ID: 28877692 [TBL] [Abstract][Full Text] [Related]
7. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection. Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527 [TBL] [Abstract][Full Text] [Related]
8. Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum. Hillier CJ; Ware LA; Barbosa A; Angov E; Lyon JA; Heppner DG; Lanar DE Infect Immun; 2005 Apr; 73(4):2109-15. PubMed ID: 15784552 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine. Longley RJ; Halbroth BR; Salman AM; Ewer KJ; Hodgson SH; Janse CJ; Khan SM; Hill AVS; Spencer AJ Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28031267 [TBL] [Abstract][Full Text] [Related]
10. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Daubersies P; Thomas AW; Millet P; Brahimi K; Langermans JA; Ollomo B; BenMohamed L; Slierendregt B; Eling W; Van Belkum A; Dubreuil G; Meis JF; Guérin-Marchand C; Cayphas S; Cohen J; Gras-Masse H; Druilhe P Nat Med; 2000 Nov; 6(11):1258-63. PubMed ID: 11062538 [TBL] [Abstract][Full Text] [Related]
11. The naturally acquired immunity in severe malaria and its implication for a PfEMP-1 based vaccine. Chen Q Microbes Infect; 2007 May; 9(6):777-83. PubMed ID: 17398133 [TBL] [Abstract][Full Text] [Related]
12. RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites. Campo JJ; Aponte JJ; Skinner J; Nakajima R; Molina DM; Liang L; Sacarlal J; Alonso PL; Crompton PD; Felgner PL; Dobaño C Mol Cell Proteomics; 2015 Mar; 14(3):519-31. PubMed ID: 25547414 [TBL] [Abstract][Full Text] [Related]
13. The march toward malaria vaccines. Hoffman SL; Vekemans J; Richie TL; Duffy PE Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116 [TBL] [Abstract][Full Text] [Related]
14. Malaria vaccine based on self-assembling protein nanoparticles. Burkhard P; Lanar DE Expert Rev Vaccines; 2015; 14(12):1525-7. PubMed ID: 26468608 [TBL] [Abstract][Full Text] [Related]
15. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas. Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641 [TBL] [Abstract][Full Text] [Related]
16. Functional Antibodies and Protection against Blood-stage Malaria. Teo A; Feng G; Brown GV; Beeson JG; Rogerson SJ Trends Parasitol; 2016 Nov; 32(11):887-898. PubMed ID: 27546781 [TBL] [Abstract][Full Text] [Related]